share_log

Virpax Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Ruskin Barbara

SEC ·  Feb 1 05:23

Summary by Futu AI

Barbara Ruskin, a reporting person for Virpax Pharmaceuticals, Inc. [VRPX], was involved in a transaction with the company's stock on January 29, 2024. The specific details of the transaction, including the action type, status, number of shares, nature of shares, transaction price, and post-transaction shareholding, were not disclosed in the announcement. Investors are advised to seek additional information to fully understand the impact of this event on their investment decisions.
Barbara Ruskin, a reporting person for Virpax Pharmaceuticals, Inc. [VRPX], was involved in a transaction with the company's stock on January 29, 2024. The specific details of the transaction, including the action type, status, number of shares, nature of shares, transaction price, and post-transaction shareholding, were not disclosed in the announcement. Investors are advised to seek additional information to fully understand the impact of this event on their investment decisions.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Doc 2

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Heat List
    US
    SymbolLatest Price% Chg

    No Data

    Hot News
    Updated